President & Chief Operating Officer, Critical Path Institute (C-Path)
Kristen Swingle was elected Chairwoman of the AZBio Board of Directors in January 2018.
Kristen serves as President and Chief Operating Officer of the Critical Path Institute (C-Path) . Prior to joining C-Path in 2019, Kristen served as the VP of Stem Cell Operations at Cord Blood Registry where she was responsible for overseeing all operations at CBR’s laboratory in Tucson, Arizona, since 2007.
Kristen has over two decades’ worth of experience in the medical and molecular sciences industry with a strong background in product development and manufacturing, quality and regulatory affairs management, project and fiscal management, and team leadership. As COO of C-Path, she is responsible for the daily operations of the organization and development and implementation of C-Path’s global strategy and goals.
Kristen holds a BS in Biology from Northern Arizona University and Master of Science (MS), Medical Sciences from Texas A&M University.
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and dozens of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Ireland, with additional staff in multiple remote locations. For more information, visit c-path.org and c-path.eu.